Key statistics
On Monday, Editas Medicine Inc (8EM:BRN) closed at 4.23, 0.00% above its 52-week low of 4.23, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.23 |
---|---|
High | 4.23 |
Low | 4.23 |
Bid | 4.22 |
Offer | 4.25 |
Previous close | 4.23 |
Average volume | -- |
---|---|
Shares outstanding | 82.48m |
Free float | 82.21m |
P/E (TTM) | -- |
Market cap | 278.77m USD |
EPS (TTM) | -2.36 USD |
Data delayed at least 15 minutes, as of Jul 01 2024.
More ▼
Announcements
- Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust
- Editas Medicine to Participate in Upcoming Investor Conferences
- Editas Medicine Announces Second Quarter 2024 Results and Business Updates
- Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update
- Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress
- Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress
- Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
- Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
- Editas Medicine Announces First Quarter 2024 Results and Business Updates
- Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
More ▼